Skip to main content
Erschienen in: CardioVasc 5/2016

03.11.2016 | Sepsis | Fortbildung_Neurologie

Das Hirn als frühes Sepsisorgan

Septische Enzephalopathie

verfasst von: Oberfeldarzt Dr. med. Sven Lerch

Erschienen in: CardioVasc | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die septische Enzephalopathie stellt eine pathophysiologisch komplexe Hirnfunktionsstörung septischer Patienten dar. Ihr Schweregrad korreliert mit der Mortalität. Häufig ist die Enzephalopathie das Erstsymptom einer Infektionserkrankung. Aufgrund dieser Tatsache und der bis heute fehlenden spezifischen Therapieoptionen ist eine frühe Erkennung mit der Chance einer umgehenden antimikrobiellen Behandlung sowie die differenzialdiagnostische Abgrenzung gegenüber anderen Ursachen eines Enzephalopathie-Syndromes entscheidend.
Literatur
1.
Zurück zum Zitat Karl Eibl: Johann Wolfgang Goethe. Samtliche Werke, Briefe, Tagebucher und Gesprache, Bd. 2. Deutscher Klassiker-Verlag: 1987, S. 107-108 Karl Eibl: Johann Wolfgang Goethe. Samtliche Werke, Briefe, Tagebucher und Gesprache, Bd. 2. Deutscher Klassiker-Verlag: 1987, S. 107-108
3.
Zurück zum Zitat Vincent JL, Sakr Y, Sprung CL et al Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53CrossRefPubMed Vincent JL, Sakr Y, Sprung CL et al Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53CrossRefPubMed
4.
Zurück zum Zitat Singer M, Deutschman CS, Seymour CW et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10CrossRefPubMedPubMedCentral Singer M, Deutschman CS, Seymour CW et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic enzephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275(6):470–3CrossRefPubMed Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic enzephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275(6):470–3CrossRefPubMed
8.
Zurück zum Zitat Papadopoulos MC, Lamb FJ, Moss RF et al. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond). 1999;96(5):461–6CrossRef Papadopoulos MC, Lamb FJ, Moss RF et al. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond). 1999;96(5):461–6CrossRef
9.
10.
Zurück zum Zitat Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature. 2006;440(7087):1054–9CrossRefPubMed Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature. 2006;440(7087):1054–9CrossRefPubMed
11.
Zurück zum Zitat Semmler A, Okulla T, Sastre M et al. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2005;30(2-3):144–57CrossRefPubMed Semmler A, Okulla T, Sastre M et al. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2005;30(2-3):144–57CrossRefPubMed
13.
Zurück zum Zitat Barr J, Fraser GL, Puntillo K et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306CrossRefPubMed Barr J, Fraser GL, Puntillo K et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306CrossRefPubMed
14.
Zurück zum Zitat Hosokawa K, Gaspard N, Su F et al. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18(6):674CrossRefPubMedPubMedCentral Hosokawa K, Gaspard N, Su F et al. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18(6):674CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Young GB, Bolton CF, Archibald YM et al. The electroenzephalogram in sepsis-associated enzephalopathy. J Clin Neurophysiol. 1992;9(1):145–52CrossRefPubMed Young GB, Bolton CF, Archibald YM et al. The electroenzephalogram in sepsis-associated enzephalopathy. J Clin Neurophysiol. 1992;9(1):145–52CrossRefPubMed
16.
Zurück zum Zitat Azabou E, Magalhaes E, Braconnier A et al. Early Standard Electroenzephalogram Abnormalities Predict Mortality in Septic Intensive Care Unit Patients. PLoS One. 2015;10(10):e0139969CrossRefPubMedPubMedCentral Azabou E, Magalhaes E, Braconnier A et al. Early Standard Electroenzephalogram Abnormalities Predict Mortality in Septic Intensive Care Unit Patients. PLoS One. 2015;10(10):e0139969CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Pierrakos C, Antoine A, Velissaris D et al. Transcranial doppler assessment of cerebral perfusion in critically ill septic patients: a pilot study. Ann Intensive Care. 2013;3:28 Pierrakos C, Antoine A, Velissaris D et al. Transcranial doppler assessment of cerebral perfusion in critically ill septic patients: a pilot study. Ann Intensive Care. 2013;3:28
18.
Zurück zum Zitat Yao B, Zhang LN, Ai YH et al. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated enzephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res. 2014;39(7):1263–9CrossRefPubMed Yao B, Zhang LN, Ai YH et al. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated enzephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res. 2014;39(7):1263–9CrossRefPubMed
20.
Zurück zum Zitat Stubbs DJ, Yamamoto AK, Menon DK. Imaging in sepsis-associated enzephalopathy—insights and opportunities. Nat Rev Neurol. 2013;9(10):551–61CrossRefPubMed Stubbs DJ, Yamamoto AK, Menon DK. Imaging in sepsis-associated enzephalopathy—insights and opportunities. Nat Rev Neurol. 2013;9(10):551–61CrossRefPubMed
21.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637CrossRefPubMed Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637CrossRefPubMed
23.
Zurück zum Zitat Flierl MA, Stahel PF, Rittirsch D et al. Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care. 2009;13(1):R12CrossRefPubMedPubMedCentral Flierl MA, Stahel PF, Rittirsch D et al. Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care. 2009;13(1):R12CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Toklu HZ, Uysal MK, Kabasakal L et al. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J Surg Res. 2009;152(2):238–48CrossRefPubMed Toklu HZ, Uysal MK, Kabasakal L et al. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J Surg Res. 2009;152(2):238–48CrossRefPubMed
25.
Zurück zum Zitat Ranieri VM, Thompson BT, Barie PS et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–64CrossRefPubMed Ranieri VM, Thompson BT, Barie PS et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–64CrossRefPubMed
26.
Zurück zum Zitat Burkhart CS, Dell-Kuster S, Siegemund M et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients. Acta Anaesthesiol Scand. 2014;58(6):689–700CrossRefPubMed Burkhart CS, Dell-Kuster S, Siegemund M et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients. Acta Anaesthesiol Scand. 2014;58(6):689–700CrossRefPubMed
27.
28.
Zurück zum Zitat Morandi A, Hughes CG, Thompson JL et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med. 2014;42(8):1899–909CrossRefPubMedPubMedCentral Morandi A, Hughes CG, Thompson JL et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med. 2014;42(8):1899–909CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Page VJ, Ely EW, Gates S et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515–23. Erratum in: Lancet Infect Dis. 2014;14(11):1040CrossRefPubMedPubMedCentral Page VJ, Ely EW, Gates S et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515–23. Erratum in: Lancet Infect Dis. 2014;14(11):1040CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Pandharipande PP, Sanders RD, Girard TD et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14(2):R38CrossRefPubMedPubMedCentral Pandharipande PP, Sanders RD, Girard TD et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14(2):R38CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94CrossRefPubMedPubMedCentral Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Semmler A, Widmann CN, Okulla T et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry. 2013;84(1):62–9CrossRefPubMed Semmler A, Widmann CN, Okulla T et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry. 2013;84(1):62–9CrossRefPubMed
33.
Zurück zum Zitat Götz T, Günther A, Witte OW et al. Long-term sequelae of severe sepsis: cognitive impairment and structural brain alterations - an MRI study (LossCog MRI). BMC Neurol. 2014;14:145CrossRefPubMedPubMedCentral Götz T, Günther A, Witte OW et al. Long-term sequelae of severe sepsis: cognitive impairment and structural brain alterations - an MRI study (LossCog MRI). BMC Neurol. 2014;14:145CrossRefPubMedPubMedCentral
Metadaten
Titel
Das Hirn als frühes Sepsisorgan
Septische Enzephalopathie
verfasst von
Oberfeldarzt Dr. med. Sven Lerch
Publikationsdatum
03.11.2016
Verlag
Springer Medizin
Erschienen in
CardioVasc / Ausgabe 5/2016
Print ISSN: 1617-4933
Elektronische ISSN: 1618-3851
DOI
https://doi.org/10.1007/s15027-016-0999-3

Weitere Artikel der Ausgabe 5/2016

CardioVasc 5/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.